Notice Number: NOT-HL-16-456
Key Dates
Release Date: September 30, 2016
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
This Notice amends the Key Dates for applications submitted to PAR-16-440 "Selected Topics in Transfusion Medicine (R01)".
Current Key Dates:
Posted Date |
September 22, 2016 |
Open Date (Earliest Submission Date) |
January 5, 2017 |
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
February 5, 2017; October 5, 2017; February 5, 2018; October 5, 2018; February 5, 2019; October 5, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
May 7, 2017; January 7, 2018; May 7, 2018; January 7, 2019; May 7, 2019; January 7, 2020, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Scientific Merit Review |
July 2017; March 2018; July 2018; March 2019; July 2019; March 2020 |
Advisory Council Review |
August 2017; May 2018; August 2018; May 2019; August 2019; May 2020 |
Earliest Start Date |
September 2017; July 2017; September 2018; July 2018; September 2019; July 2019 |
Expiration Date |
January 8, 2020 |
Due Dates for E.O. 12372 |
Not Applicable |
Updated Key Dates:
Posted Date |
September 22, 2016 |
Open Date (Earliest Submission Date) |
October 21, 2016 |
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
November 21, 2016; February 5, 2017; October 5, 2017; February 5, 2018; October 5, 2018; February 5, 2019; October 5, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
January 7, 2017; May 7, 2017; January 7, 2018; May 7, 2018; January 7, 2019; May 7, 2019; January 7, 2020, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
Scientific Merit Review |
February 2017; July 2017; March 2018; July 2018; March 2019; July 2019; March 2020 |
Advisory Council Review |
May 2017; October 2017; May 2018; October 2018; May 2019; October 2019; May 2020 |
Earliest Start Date |
July 2017; November 2017; July 2017; November 2018; July 2018; November 2019; July 2020 |
Expiration Date |
January 8, 2020 |
Due Dates for E.O. 12372 |
Not Applicable |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Shimian Zou, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: [email protected]